Search Result

Results for "

Glucosidase

" in MedChemExpress (MCE) Product Catalog:

By Targets:	AMPK (1) Amylases (26) Angiotensin-converting Enzyme (ACE) (1) Antibiotic (4) Apoptosis (11) Aryl Hydrocarbon Receptor (3) Bacterial (9) Bcl-2 Family (1) Biochemical Assay Reagents (6) Carbonic Anhydrase (1) Cholinesterase (ChE) (5) COX (2) Dengue virus (3) Dipeptidyl Peptidase (6) DNA/RNA Synthesis (2) Endogenous Metabolite (17) Enterovirus (1) Estrogen Receptor/ERR (1) Flavivirus (3) Fluorescent Dye (3) Fungal (3) Glucokinase (2) Glutaminase (1) Glutathione Peroxidase (2) Glycosidase (252) HBV (2) HCV (2) HDAC (1) HIV (4) HIV Protease (1) HMG-CoA Reductase (HMGCR) (2) Influenza Virus (2) Interleukin Related (2) Isotope-Labeled Compounds (3) Lipoxygenase (3) NOD-like Receptor (NLR) (1) Opioid Receptor (2) P-glycoprotein (1) Parasite (3) Phosphatase (7) Phospholipase (1) PI3K (3) PKC (1) PPAR (5) Reactive Oxygen Species (3) TNF Receptor (2) Tyrosinase (4) α-synuclein (2)
By Research Areas:	Cancer (33) Cardiovascular Disease (10) Endocrinology (7) Infection (39) Inflammation/Immunology (25) Metabolic Disease (197) Neurological Disease (17)
Click Chemistry:	Azide (1)

296

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

127

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

*α-Glucosidase, Yeast* α-D-Glucosidase, Yeast	Glycosidase	Metabolic Disease
α-Glucosidase, Yeast (α-D-Glucosidase, Yeast), a carbohydrate hydrolyzing enzyme, catalyzes the liberation of α-glucose from the non-reducing end of the substrate. α-Glucosidase can facilitate the absorption of glucose by the small intestine. Inhibition of α-Glucosidase is an effective management of non-insulin-dependent diabetes mellitus (NIDDM) .

*β-Glucosidase, almond* 1 Publications Verification	Glycosidase	Others
β-Glucosidase, almond is the rate-limiting enzyme of degradation of cellulose. β-Glucosidase is a major group among glycoside hydrolases. β-Glucosidase is involved in the degradation of cellulose in soils and has potential for monitoring biological soil quality .

*α-Glucosidase-IN-32*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-32 (compound f26) is a reversible, noncompetitive and orally active α-glucosidase inhibitor with an IC₅₀ value of 3.07 μM. α-Glucosidase-IN-32 complex with α-glucosidase through hydrogen bonds and hydrophobic interactions, led to changes in the conformation and secondary strictures of α-glucosidase and further the inhibition of the enzymatic activity. α-Glucosidase-IN-32 can be used for diabetic disease research .

*α-Glucosidase-IN-23*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-23 is an orally active *α-Glucosidase* inhibitor. α-Glucosidase-IN-23 decreases blood glucose by a-glucosidase inhibition with an IC₅₀ value of 4.48 μM. α-Glucosidase-IN-23 can be used for the research of diabetes .

*α-Glucosidase-IN-11*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-11 is a highly permeable competitive *α-glucosidase* inhibitor with the IC₅₀ value of 0.56 μM. α-Glucosidase-IN-11 binds to Trp residues in α-glucosidase and regulates protein folding. α-Glucosidase-IN-11 can be used to regulate blood glucose levels .

*α-Glucosidase-IN-47*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-47 (compound 8H) is a non-competitive α-glucosidase (α-glucosidase) inhibitor with IC₅₀ value is 38.2 μM and K_i value is 38.2 μM. α-Glucosidase-IN-47 can be used in diabetes research. .

*α-Glucosidase-IN-63*	Glycosidase Carbonic Anhydrase	Endocrinology
α-Glucosidase-IN-63 (Compound 4d) is an inhibitor of *α-Glucosidase* (IC₅₀=0.44 μM). α-Glucosidase-IN-63 inhibits hCA II with an activity of K_i= 7.0 nM. α-Glucosidase-IN-63 is orally effective. .

*α-Glucosidase-IN-28*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-28 (Compound 18) is a *α-Glucosidase* inhibitor (IC₅₀: 0.62 μM, K_i: 3.93 μM). α-Glucosidase-IN-28 binds to α-glucosidase at the original binding site (OBS), and forms multiple hydrophobic interactions with nearby amino acids. α-Glucosidase-IN-28 can be used for research of diabetes and related diseases .

*α-Glucosidase-IN-50*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-50 (compound 8) is an inhibitor of *α-Glucosidase* .

*α-Glucosidase-IN-51*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-51 (compound 9) is an inhibitor of *α-Glucosidase* .

*α-Glucosidase-IN-2*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-2 (compound 5d) is a potent *α-Glucosidase* inhibitor with an IC₅₀ of 9.48 µM. α-Glucosidase-IN-2 is an antidiabetic agent .

*α-Glucosidase-IN-24*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-24 (Compound 13) is an *α-Glucosidase* inhibitor with an IC₅₀ of 451 μM. α-Glucosidase-IN-24 can be isolated from Swertia kouitchensis .

*α-Glucosidase-IN-39*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-39 is a potent inhibitor of *α-glucosidase* enzyme with an IC₅₀** of 869.06 ppm. α-Glucosidase-IN-39 can used in study antidiabetic .

*α-Glucosidase-IN-44*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-44 (compound IT4) is an inhibitor of *α-glucosidase* with IC₅₀ value of 2.35 μM. α-Glucosidase-IN-44 has an oral activity. α-Glucosidase-IN-44 suppresses fasting blood glucose levels in diabetic mice .

*α-Glucosidase-IN-73*	Glycosidase	Metabolic Disease Inflammation/Immunology
α-Glucosidase-IN-73 (compound 16b) is an *α-Glucosidase* inhibitor with IC₅₀ of 0.158 μM. α-Glucosidase-IN-73 can activate PPAR γ. α-Glucosidase-IN-73 can be used in anti-diabetic and anti-inflammatory studies .

*α-Glucosidase-IN-36*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-36 (compound 5g) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 6.69 ± 0.18 μM, K_i and K_is of 1.65 μM and 4.54 μM, respectively. α-Glucosidase-IN-36 may inhibit α-glucosidase activity by binding with its active site as well as changing the secondary structure of α-glucosidase. α-Glucosidase-IN-36 can be used for type 2 diabetes mellitus (T2DM) research .

*α-Glucosidase-IN-35*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-35 (compound 1) is a kind of chromene. α-Glucosidase-IN-35 can be isolated from the aqueous extract of the aerial parts of Brickellia cavanillesii. α-Glucosidase-IN-35 is a potent inhibitor of *α-glucosidase* with an IC₅₀ value of 0.169 mg/mL .

*α-Glucosidase-IN-6*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-6 (compound 18) is a competitive *α-glucosidase* inhibitor with an IC₅₀ of 5.69 µM. α-Glucosidase-IN-6 has anti-diabetic potential .

*α-Glucosidase-IN-46*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-46 is a potent *α-glucosidase* inhibitor with an IC₅₀ of 26.0 μM. α-Glucosidase-IN-46 can be used for the research of type 2 diabetes .

*α-Glucosidase-IN-52*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-52 (Compound 3h) is an *α-glucosidase* inhibitor with an IC₅₀ of 2.8 μM. α-Glucosidase-IN-52 can be used for diabetes research .

*α-Glucosidase-IN-41*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-41 (compound 5o) is a potent *α-glucosidase* inhibitor. α-Glucosidase-IN-41 can arise the changed secondary structure of α-Glu to hinder enzyme catalytic activity. α-Glucosidase-IN-41 can be used for diabetes mellitus research .

*α-Glucosidase-IN-42*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-42 (Compound 26) is a 9-O-berberrubine carboxylate derivative. α-Glucosidase-IN-42 has potent α-glucosidase inhibitory activities with an IC₅₀ value in the range of 1.61 μM. α-Glucosidase-IN-42 can be used for the research of antidiabetic .

*α-Glucosidase-IN-67*	Amylases Glycosidase	Metabolic Disease
α-Glucosidase-IN-67 (compound 5k) is a potent *α-Glucosidase* inhibitor with IC₅₀ values of 0.31, 4.51 µM for alpha-glucosidase and alpha-amylase, respectively. α-Glucosidase-IN-67 has the potential for the research of type-2 diabetes .

*α-Glucosidase-IN-5*	Glutaminase	Metabolic Disease
α-Glucosidase-IN-5 (compound 8) is a potent *α-glucosidase* inhibitor with an IC₅₀ of 57.9 µM. α-Glucosidase-IN-5 has the potential for the research of diabetes mellitus .

*α-Glucosidase-IN-18*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-18 (7B) is an orally active *α-glucosidase* inhibitor with an IC₅₀ value of 3.96 μM. α-Glucosidase-IN-18 has antidiabetic activity .

*α-Glucosidase-IN-9*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-9 (compound 7) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 55.6 μM. α-Glucosidase-IN-9 can be used for type II diabetes research .

*α-Glucosidase-IN-10*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-10 (compound 13) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 92.7 μM. α-Glucosidase-IN-10 can be used for type II diabetes research .

*α-Glucosidase-IN-17*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-17 (Compound 12B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.79 μM. α-Glucosidase-IN-17 shows antidiabetic activity .

*α-Glucosidase-IN-15*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-15 (Compound 14B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.34 μM. α-Glucosidase-IN-15 shows antidiabetic activity .

*α-Glucosidase-IN-21*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-21 (Compound 2B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 2.62 μM. α-Glucosidase-IN-21 shows anti-diabetic activity .

*α-Glucosidase-IN-19*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-19 (Compound 6B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.63 μM. α-Glucosidase-IN-19 shows anti-diabetic activity .

*α-Glucosidase-IN-20*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-20 (Compound 3B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.01 μM. α-Glucosidase-IN-20 shows anti-diabetic activity .

*α-Glucosidase-IN-45*	Glycosidase	Cancer
α-Glucosidase-IN-45 (compound 11E) is an inhibitor of *α-glucosidase. α-Glucosidase*-IN-45 is a novel indol-fused pyrano[2,3-D]pyrimidine compound .

*α-Glucosidase-IN-54*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-54 (compound 2) is a *α-glucosidase* inhibitor with the IC₅₀ of 0.011 mM, and can be isolated form Syzygium jambos (L.). α-Glucosidase-IN-54 can be used for study of diabetes .

*α-Glucosidase-IN-65*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-65 (compound 5) is a Schiff base derivative of 3,4-dihydroxyphenylacetic acid. α-Glucosidase-IN-65 is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 12.84 μM .

*α-Glucosidase-IN-75*	Glycosidase	Cardiovascular Disease Metabolic Disease
α-Glucosidase-IN-75 (compound 13) is an *α-glucosidase* inhibitor with an IC₅₀ of 3.81 μM. α-Glucosidase-IN-75 can be used for the study of high glucose-induced cardiovascular diseases .

*α-Glucosidase-IN-56*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-56 (compound 1) is an orally active, potent *α‐glucosidase* inhibitor with an IC₅₀ value of 45.86 μM. α-Glucosidase-IN-56 has potent anti-glycation activities .

*α-Glucosidase-IN-7*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-7 is a noncompetitive *α-glucosidase* inhibitor with an IC₅₀ value of 18.9 µM .

*α-Glucosidase-IN-13*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-13 (Compound 8) is a *α-glucosidase* inhibitor with an IC₅₀ of 5.69 μM .

*α-Glucosidase-IN-38*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-38 (Compound 11j) is a potent inhibitor of α-glucosidase inhibitor with IC₅₀ *of 12.44±0.38 μM.α-Glucosidase-IN-38 plays an important role in Diabetes mellitus (DM) .*

*α-Glucosidase-IN-64*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-64 (compound 10) is a potent *α-glucosidase* inhibitor with an IC₅₀ value of 8.62 µM. α-Glucosidase-IN-64 is a polycyclic polyprenylated acylphloroglucinol that can be isolated from hypericum beanii .

*α-Glucosidase-IN-69*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-69 (compound 5k) is a competitive *α-glucosidase* inhibitor with an IC₅₀ of 26.8 µM and a K_i value of 26.0 µM. α-Glucosidase-IN-69 has the potential for the diabetes research .

*α-Glucosidase-IN-78*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-78 (Compound 12m) is an inhibitor for *α-glucosidase* with a reversible, competitive IC₅₀ 6.0 μM. α-Glucosidase-IN-78 can be used in research of diabete for its hypoglycemic property .

*α-Glucosidase-IN-76*	Glycosidase	Cancer
α-Glucosidase-IN-76 (Compound 4r) is an inhibitor for *α-glucosidase* with an IC₅₀ of 5.44 μM. α-Glucosidase-IN-76 scavenges ABTS+ free radicals with a TEAC value of 0.49. α-Glucosidase-IN-76 inhibits the proliferation of T24 bladder cancer cell with IC₅₀ of 1.74 μM .

*α-Glucosidase-IN-27*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-27 (compound 8l) is an α-glucosidase inhibitor (IC₅₀=25.78 μM). α-Glucosidase-IN-27 has the potential to study type 2 diabetes (D2M) .

*α-Glucosidase-IN-37*	Others	Inflammation/Immunology
α-Glucosidase-IN-37 (Compound 11) moderately inhibits LPS-induced NO production with an IC₅₀ value of 23.7 μM in macrophages. α-Glucosidase-IN-37 has weak inhibitory activity against α-Glucosidase .

Cat. No.	Product Name	Type

HY-W357142

3-Acetylumbelliferyl β-D-Glucopyranoside	Chromogenic Substrates Fluorescent Dyes/Probes
3-Acetylumbelliferyl β-D-Glucopyranoside is a fluorogenic substrate for β-glucosidase and can be used as a positive control substrates for β-D-glucosidase .

Cat. No.	Product Name	Type

HY-W005598

2-Hydroxyquinoline	Biochemical Assay Reagents
2-Hydroxyquinoline is a potent *α-glucosidase* inhibitor with IC₅₀ values of 64.4, 130.5 µg/mL for α-glucosidase and α-amylase, respectively. 2-Hydroxyquinoline has the potential for the research of diabetes .

HY-129217

Naringinase	Biochemical Assay Reagents
Naringinase, a hydrolytic enzymatic complex, possesses the activity of both α-L-rhamnosidase and β-D-glucosidase. Naringinase has wide occurrence in nature. Naringinase can be used in the biotransformation of steroids, antibiotics, and mainly on glycosides hydrolysis .

HY-15927

4-Nitrophenyl β-D-glucopyranoside

1 Publications Verification

Enzyme Substrates

4-Nitrophenyl β-D-glucopyranoside is a chromogenic substrate for β-glucosidase. 4-Nitrophenyl β-D-glucopyranoside is converted to a colored product, p-nitrophenol that is easily detected spectrophotometrically at 405 nm when used in a β-glycosidase assay. 4-Nitrophenyl β-D-glucopyranoside is hydrolysed through intramolecular nucleophilic catalysis by the phosphate group in the 2-position. 4-Nitrophenyl β-D-glucopyranoside is promising for research of postmenopausal osteoporosis .

HY-E70183

Lysosomal α-Glucosidase EC:3.2.1.20; GAA	Enzyme Substrates
Lysosomal α-Glucosidase (EC:3.2.1.20) is a γ-amylase with specificity for glycogen and several natural and synthetic oligoglucosides .

HY-W826489

D-Glucopyranose, 98% α-Sophorose, 98%	Carbohydrates
D-Glucopyranose, 98% serves as a substrate for various glycosidase enzymes, including α-glucosidase, and is also used in glycobiology research.

HY-W039859

2-Chloro-4-nitrophenyl β-D-glucopyranoside, 98%	Carbohydrates
2-Chloro-4-nitrophenyl β-D-glucopyranoside, 98% is a substrate for β-glucosidase, used as a bacterial growth medium.

HY-136868

Resorufin-β-D-glucopyranoside, 98% 3-Phenoxazone 7-(β-D-glucopyranoside),98%	Carbohydrates
Resorufin-β-D-glucopyranoside, 98% (3-Phenoxazone 7-(β-D-glucopyranoside), 98%) can be used to detect and quantify β-glucosidase activity in various biological samples.

Cat. No.	Product Name	Target	Research Area

HY-138815

(S)-N-(1H-Indole-3-acetyl)tryptophan	Glycosidase	Metabolic Disease
(S)-N-(1H-Indole-3-acetyl)tryptophan (compound 4a) is a Tryptophan derivative that weakly inhibits *β-D-glucosidase* .

HY-P5201S1

VTSEGAGLQLQK-13C6,15N2 TFA	Isotope-Labeled Compounds	Others
VTSEGAGLQLQK- ¹³C₆, ¹⁵N₂ (TFA) is the ¹³C- and ¹⁵N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .

Cat. No.	Product Name	Target	Research Area

HY-P99803

Clervonafusp alfa VAL-1221	Glycosidase	Others
Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research .

Species:	Human (1) Mouse (1)
Tag:	His (3) Tag Free (2) Strep (1) GST (1) Flag (1)
Source:	HEK293 (1) E. coli (5)

Cat. No.	Compare	Product Name	Species	Source

HY-P71650

	*Cytosolic beta-Glucosidase/GBA3 Protein, Human (GST)* CBG; CBGL1; Cytosolic beta Glucosidase ; Cytosolic beta Glucosidase like protein 1; Cytosolic beta-Glucosidase; Glucosidase beta acid 3; Klotho related protein ; KLRP	Human	E. coli
	Cytosolic β-glucosidase/GBA3 is a multifunctional neutral cytosolic β-glucosidase that displays broad substrate specificity, suggesting a possible involvement in glycosylceramide catabolism. Although it exhibits significant glucosylceramidase activity in vitro, its in vivo relevance is unclear. Cytosolic beta-Glucosidase/GBA3 Protein, Human (GST) is the recombinant human-derived Cytosolic beta-Glucosidase/GBA3 protein, expressed by E. coli , with N-GST labeled tag.

HY-P703073

	GBA/Glucosylceramidase Protein, Mouse (HEK293, His) Acid beta-Glucosidase; Beta-glucocerebrosidase; SGTase; Cholesteryl-beta-Glucosidase	Mouse	HEK293
	GBA/glucosylceramidase protein catalyzes the hydrolysis of glucosylceramide/GlcCers into free ceramide and glucose within lysosomes. It plays a key role in lipid degradation and cell membrane turnover. GBA/Glucosylceramidase Protein, Mouse (HEK293, His) is the recombinant mouse-derived GBA/Glucosylceramidase protein, expressed by HEK293 , with N-10*His labeled tag.

HY-P702159

	pulB Protein, Pullulanibacillus naganoensis pulB; Alpha-dextrin endo-1; 6-alpha-Glucosidase; Pullulan 6-glucanohydrolase	Others	E. coli
	PulB is a protein belonging to the glycosyl hydrolase 13 family. The glycosyl hydrolase 13 family contains enzymes involved in the breakdown of complex carbohydrates by catalyzing the hydrolysis of glycosidic bonds. pulB Protein, Pullulanibacillus naganoensis is the recombinant pulB protein, expressed by E. coli , with tag free. The total length of pulB Protein, Pullulanibacillus naganoensis is 926 a.a., .

HY-P702160

	pulB Protein, Pullulanibacillus naganoensis (FLAG, His) pulB; Alpha-dextrin endo-1; 6-alpha-Glucosidase; Pullulan 6-glucanohydrolase	Others	E. coli
	PulB is a protein belonging to the glycosyl hydrolase 13 family. The glycosyl hydrolase 13 family contains enzymes involved in the breakdown of complex carbohydrates by catalyzing the hydrolysis of glycosidic bonds. pulB Protein, Pullulanibacillus naganoensis (FLAG, His) is the recombinant pulB protein, expressed by E. coli , with N-6*His, N-Flag labeled tag. The total length of pulB Protein, Pullulanibacillus naganoensis (FLAG, His) is 926 a.a., .

HY-P703445

	susB Protein, Bacteroides thetaiotaomicron Glucan 1,4-alpha-Glucosidase SusB; Alpha-Glucosidase SusB; Glucoamylase SusB; Starch-utilization system protein B; susB; Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50); Glycosidase; Hydrolase; 3.2.1.3	Others	E. coli
	susB Protein, Bacteroides thetaiotaomicron is the recombinant susB, expressed by E. coli , with tag Free labeled tag. ,

HY-P703446

	susB Protein, Bacteroides thetaiotaomicron (His, Strep) Glucan 1,4-alpha-Glucosidase SusB; Alpha-Glucosidase SusB; Glucoamylase SusB; Starch-utilization system protein B; susB; Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50); Glycosidase; Hydrolase; 3.2.1.3	Others	E. coli
	susB Protein, Bacteroides thetaiotaomicron (His, Strep) is the recombinant susB, expressed by E. coli , with Strep, His labeled tag. ,

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-P5201S

VTSEGAGLQLQK-13C6,15N2
VTSEGAGLQLQK- ¹³C₆, ¹⁵N₂ is the ¹³C and ¹⁵N labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA). VTSEGAGLQLQK can be used to bind anti-drug antibodies (ADA) in plasma and quantitatively analyze the therapeutic effect .

HY-P5201S1

VTSEGAGLQLQK-13C6,15N2 TFA
VTSEGAGLQLQK- ¹³C₆, ¹⁵N₂ (TFA) is the ¹³C- and ¹⁵N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .

HY-138815S

(S)-N-(1H-Indole-3-acetyl)tryptophan-d4
(S)-N-(1H-Indole-3-acetyl)tryptophan-d₄ is deuterium labeled (S)-N-(1H-Indole-3-acetyl)tryptophan. (S)-N-(1H-Indole-3-acetyl)tryptophan (compound 4a) is a Tryptophan derivative that weakly inhibits *β-D-glucosidase* .

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80405

	Glucosidase 2 subunit beta Antibody	WB, IHC-P, ICC/IF	Human
	Glucosidase 2 subunit beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa., targeting to Glucosidase 2 subunit beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.

HY-P83127

	GAA Antibody (YA2872) Acid maltase; GAA; Glucosidase alpha acid; LYAG	WB	Human, Mouse, Rat
	GAA Antibody (YA2872) is a biotin-conjugated non-conjugated IgG antibody, targeting GAA, with a predicted molecular weight of 105 kDa (observed band size: 120,100,75 kDa). GAA Antibody (YA2872) can be used for WB experiment in human, mouse, rat background.